Parallel Advisors’s Dr. Reddy's Laboratories RDY Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.18M Buy
78,440
+29,375
+60% +$442K 0.02% 373
2025
Q1
$647K Sell
49,065
-23,725
-33% -$313K 0.01% 503
2024
Q4
$1.15M Sell
72,790
-70
-0.1% -$1.11K 0.03% 357
2024
Q3
$1.16M Buy
72,860
+10,750
+17% +$171K 0.03% 356
2024
Q2
$946K Buy
62,110
+7,350
+13% +$112K 0.02% 371
2024
Q1
$803K Buy
54,760
+22,190
+68% +$326K 0.02% 405
2023
Q4
$453K Buy
32,570
+1,885
+6% +$26.2K 0.01% 520
2023
Q3
$410K Buy
30,685
+8,615
+39% +$115K 0.01% 517
2023
Q2
$279K Buy
22,070
+1,025
+5% +$12.9K 0.01% 645
2023
Q1
$240K Buy
21,045
+5,720
+37% +$65.1K 0.01% 689
2022
Q4
$159K Sell
15,325
-12,430
-45% -$129K 0.01% 801
2022
Q3
$291K Buy
27,755
+5,275
+23% +$55.3K 0.01% 551
2022
Q2
$249K Buy
22,480
+3,090
+16% +$34.2K 0.01% 593
2022
Q1
$220K Buy
19,390
+1,470
+8% +$16.7K 0.01% 688
2021
Q4
$234K Sell
17,920
-1,250
-7% -$16.3K 0.01% 683
2021
Q3
$250K Buy
19,170
+285
+2% +$3.72K 0.01% 630
2021
Q2
$278K Buy
18,885
+1,000
+6% +$14.7K 0.01% 559
2021
Q1
$220K Sell
17,885
-135
-0.7% -$1.66K 0.01% 604
2020
Q4
$257K Sell
18,020
-2,345
-12% -$33.4K 0.01% 510
2020
Q3
$283K Buy
20,365
+485
+2% +$6.74K 0.02% 440
2020
Q2
$210K Sell
19,880
-3,975
-17% -$42K 0.01% 525
2020
Q1
$192K Buy
23,855
+9,810
+70% +$79K 0.02% 452
2019
Q4
$114K Buy
14,045
+5,005
+55% +$40.6K 0.01% 720
2019
Q3
$68K Buy
9,040
+2,650
+41% +$19.9K 0.01% 861
2019
Q2
$48K Buy
6,390
+1,165
+22% +$8.75K ﹤0.01% 914
2019
Q1
$42K Buy
5,225
+3,305
+172% +$26.6K ﹤0.01% 910
2018
Q4
$14K Buy
1,920
+330
+21% +$2.41K ﹤0.01% 1200
2018
Q3
$11K Sell
1,590
-250
-14% -$1.73K ﹤0.01% 1404
2018
Q2
$11K Buy
1,840
+1,015
+123% +$6.07K ﹤0.01% 1307
2018
Q1
$5K Sell
825
-1,400
-63% -$8.49K ﹤0.01% 1571
2017
Q4
$17K Buy
2,225
+1,860
+510% +$14.2K ﹤0.01% 1089
2017
Q3
$3K Sell
365
-1,110
-75% -$9.12K ﹤0.01% 1772
2017
Q2
$11K Buy
1,475
+1,155
+361% +$8.61K ﹤0.01% 1284
2017
Q1
$3K Hold
320
﹤0.01% 1696
2016
Q4
$3K Buy
+320
New +$3K ﹤0.01% 1545